Propranolol suppresses bladder cancer by manipulating intracellular pH via NHE1

BACKGROUND: In recent years, a large number of clinical and epidemiological studies have revealed the anti-cancer activity of propranolol in solid tumors, though the underline mechanism is yet to be clarified. METHODS: The proliferation of bladder cancer cells treated with propranolol was detected b...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Qian, Hu, Jiali, Chen, Cuiyu, Wang, Yang, Zhang, Yu, Wan, Jielin, Jing, Ouyang, Yi, Hanying, Wang, Shiyu, Huang, Weihua, Liu, Jie, Zhang, Wei, McLeod, Howard L., Xu, Ran, He, Yijing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459546/
https://www.ncbi.nlm.nih.gov/pubmed/36092839
http://dx.doi.org/10.21037/tau-22-113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459546/
https://www.ncbi.nlm.nih.gov/pubmed/36092839
http://dx.doi.org/10.21037/tau-22-113

Ejemplares similares